CA23859-3 - 0x000000000000341A

Study Number: CA23859
Group Number: 3
Study Requirement: Cystic Fibrosis
Stipend: up to £ 1,487

Study Criteria:

  • Age: 18 - 0
  • BMI: 16 - 29.9
  • Weight Restriction: minimum weight 0 lbs

Study Information:

  • Indication: This investigational medication is being developed to treat Cystic Fibrosis.
  • Route of Administration: Oral
  • Blood Draws: 17

Study Schedule:

  • Schedule Type: Return Only
  • Study Length: 7 Returns & 3 Phone Calls

Screening Dates:

Event Day Event Date Site
No search results

Doctor Exam Dates:

Event Day Event Date Site
No search results

Study Dates:

Event Type Start Day Start Date End Day End Date Phase Site
Return Monday Jun 4 2018 8:15AM Monday Jun 4 2018 9:30AM 1 Belfast
Return Tuesday Jun 5 2018 6:30AM Tuesday Jun 5 2018 9:30PM 1 Belfast
Return Wednesday Jun 6 2018 8:15AM Wednesday Jun 6 2018 10:00AM 1 Belfast
Phone participant* Sunday Jun 10 2018 12:00PM 1 Belfast
Return Monday Jun 11 2018 7:45AM Monday Jun 11 2018 11:45AM 1 Belfast
Phone participant* Sunday Jun 17 2018 12:00PM 1 Belfast
Return Monday Jun 18 2018 7:45AM Monday Jun 18 2018 9:30PM 1 Belfast
Return Tuesday Jun 19 2018 8:30AM Tuesday Jun 19 2018 9:30AM 1 Belfast
Phone participant* Sunday Jun 24 2018 10:00PM 1 Belfast
Return Monday Jun 25 2018 8:00AM Monday Jun 25 2018 11:00AM 1 Belfast